Does SITAGLIPTIN Cause Affect lability? 244 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 244 reports of Affect lability have been filed in association with SITAGLIPTIN (JANUVIA). This represents 1.2% of all adverse event reports for SITAGLIPTIN.
244
Reports of Affect lability with SITAGLIPTIN
1.2%
of all SITAGLIPTIN reports
0
Deaths
236
Hospitalizations
How Dangerous Is Affect lability From SITAGLIPTIN?
Of the 244 reports, 236 (96.7%) required hospitalization, and 218 (89.3%) were considered life-threatening.
Is Affect lability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 244 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Affect lability?
DULOXETINE (2,510)
METFORMIN (291)
AMLODIPINE (274)
METHOTREXATE (266)
ATORVASTATIN (259)
IRBESARTAN (257)
LEVOTHYROXINE (251)
ESOMEPRAZOLE (234)
ASPIRIN (224)
PREDNISONE (196)
Which SITAGLIPTIN Alternatives Have Lower Affect lability Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE